weight loss drugs non glp 1 Life after weight-loss Understanding Weight Loss Medications: GLP-1

Eur J Nucl Med Mol Imagin

References: Elective perioperative management of adults taking glucagonlike peptide1 receptor agonists, glucosedependent insulinotropic peptide agonists and sodiumglucose cotransporter2 inhibitors: A multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association

Traditional approaches to obesity management, including lifestyle interventions and older pharmacotherapies, have historically demonstrated limited long-term efficacy, creating an urgent need for more effective therapeutic options

In a 2023 case report, a 31-year-old appropriately fasted female on Ozempic was found to have significant amounts of solid food in her stomach during endoscopy

Mechanisms of amylin/leptin synergy in rodent models

Pregnancy-related outcomes for women with polycystic ovary syndrome